Neuroscientist Travis Baker Receives Cutting-Edge Basic Research Award From NIH

Congratulations to Travis Baker, Associate Professor at Rutgers University–Newark’s Center for Molecular and Behavioral Neuroscience (CMBN), receiving the Cutting-Edge Basic Research Award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).

2023-2025. “Closed-loop neuromodulation of the brain reward system in nicotine use disorder”. Cutting-Edge Basic Research Award (NIH R21).

Principal Investigator: Travis E. Baker, PhD
Co-investigator: Drew Headley, PhD

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.